Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are delighted to share the latest issue of touchREVIEWS in Ophthalmology, showcasing a diverse range of articles that highlight the innovation, interdisciplinary collaboration and continued advances driving progress in eye care today. We begin this issue with an important and under-explored topic, as Fatma et al. present an investigative review examining the potential association […]

Search Results

Showing Results for Regillo

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Developed by Touch
Coverage from: Hawaiian Eye and Retina Highlights

It was a pleasure to catch up with Dr Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA) about new and emerging neovascular age-related macular degeneration treatments, including the new anti-vascular endothelial growth factor which appear to lead to better outcomes ...

Developed by Touch
Coverage from: Hawaiian Eye and Retina Highlights

It was a pleasure to catch up with Dr Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA) about the problems with the clinical utility of vascular endothelial growth factor inhibitors and the issues around durability and ensuring good outcomes in ...

Mark CompleteCompleted
BookmarkBookmarked
Coverage from: Hawaiian Eye and Retina Highlights

The Hawaiian Eye and Retina 2022 meeting was held in Waikoloa Village, Hawaii, from January 15 to 21. Meeting attendees were updated on the latest developments in ophthalmology, with the expert faculty covering a broad range of topics, including recommendations for best practice. ...

Developed by Touch
Coverage from: Hawaiian Eye and Retina Highlights

There are new treatment options for patients with wet age-related macular degeneration emerging, according to a presentation at Hawaiian Eye 2022. It was a pleasure to speak with Dr Carl Regillo (Thomas Jefferson University, Philadelphia, PA, USA) about his views on ...

Developed by Touch
Coverage from: Hawaiian Eye and Retina Highlights

A new ranibizumab injection offers hope for patients with wet age-related macular degeneration, according to a presentation at Hawaiian Eye 2022. It was great to catch up with Dr Carl Regillo (Thomas Jefferson University, Philadelphia, PA, USA), who talked to us ...

Coverage from: Hawaiian Eye and Retina Highlights

It was a pleasure to catch up with Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA), who talked us through the therapeutic approaches currently in clinical trial investigation for the treatment of geographic atrophy, and his views on exciting future ...

Coverage from: Hawaiian Eye and Retina Highlights

We enjoyed speaking to Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA) about incidence and prognosis of geographic atrophy, and advances in understanding of genetics and pathophysiology of dry AMD. Questions Could you give us a brief overview of geographic ...

Mark CompleteCompleted
BookmarkBookmarked

Authored by Vanessa Lane, PhD, Senior Medical Writer, Touch Medical Media, UK Diabetic macular oedema (DMO) affects around 1–12% of diabetic patients,1 and is defined as retinal thickening involving or approaching the centre of the macula.2 It represents the most common ...

Close Popup